This study is not yet accepting patients
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT05242484
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 550 study participants
- Last Updated